LABORATORIOS FARMACEUTICOS ROVI, S.A. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 82.9 EUR | +0.24% |
|
+2.80% | +37.38% |
| Apr. 02 | Spain's Rovi Obtains US FDA Approval for Marketing Risvan as Schizophrenia Treatment | MT |
| Mar. 12 | Rovi, Partners to Form Entity for Advanced Therapies R&D | MT |
